AstraZeneca on Thursday appointed company insider Rick Suarez as the head of its U.S. biopharmaceuticals unit to lead the ...
AstraZeneca’s new head of Investor Relations, Joris Silon, succeeds Andy Barnett on 1 March 2026, and will be based in ...
Nasdaq on Friday said U.S. retailer Walmart will replace British drugmaker Astrazeneca in the Nasdaq-100 Index effective on ...
If you are wondering whether AstraZeneca shares still offer fair value after a strong run, or if you might be paying too much for the story, this article is designed to help you frame that question ...
Why AstraZeneca is on investors’ radar today AstraZeneca (LSE:AZN) has been drawing attention after a period of solid share price gains. This is prompting investors to reassess how its current ...
Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.
AstraZeneca has named Rick R. Suarez as Senior Vice President, U.S. President and Head of the U.S. Biopharmaceuticals ...
On Jan. 4, 2021, a COVID-19 vaccine developed by AstraZeneca and Oxford University was administered for the first time, to an ...
US biotech BostonGene has struck a research collaboration with British pharma AstraZeneca (LSE: AZN) to explore the use of ...
BostonGene, the developer of the leading AI foundation model for tumor and immune biology, today announced a strategic collaboration with AstraZeneca, a global, science-led biopharmaceutical company ...
Over 3.4 million people globally are affected by SLE, and it is one of the leading causes of death in young women in the US ...
AstraZeneca on Thursday appointed company insider Rick Suarez as the head of its U.S. biopharmaceuticals unit to lead the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results